Conteduca, V., Gurioli, G., Rossi, L., Scarpi, E., Lolli, C., Schepisi, G., . . . De Giorgi, U. (2018). Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer. BMC Cancer.
Citação norma ChicagoConteduca, Vincenza, et al. "Oxaliplatin Plus Leucovorin and 5-fluorouracil (FOLFOX-4) As a Salvage Chemotherapy in Heavily-pretreated Platinum-resistant Ovarian Cancer." BMC Cancer 2018.
Citação norma MLAConteduca, Vincenza, et al. "Oxaliplatin Plus Leucovorin and 5-fluorouracil (FOLFOX-4) As a Salvage Chemotherapy in Heavily-pretreated Platinum-resistant Ovarian Cancer." BMC Cancer 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.